Abstract:Multidrug resistance in tumor cells poses a major obstacle to efficient chemotherapy. Several types of agents have been recognized as multidrug resistance inhibitors, among which the tetrahydroisoquinolines is the most studied. In current study 16 furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline were synthesized. Their cytotoxic activities and effects in reversing multidrug resistance have been evaluated. The results revealed that these compounds had moderate cytotoxic effects. Compounds 7a-f, 7h, and 7l showed higher cytotoxicities than the rest, but lower than adriamycin on K562 cell line. Compounds 7d, 7f, and 7l exhibited potent MDR reversal activities on K562/A02 cell line. The accumulation assay indicated that compounds 7d, 7f, and 7l significantly increased the intracellular accumulation of rhodamine123 in K562/A02 cells. Furthermore, these three compounds produced high concentrations of NO in K562/A02 cells. Potentially, the high concentrations of NO produced by NO donor moieties will lead to an increased cytotoxicity to K562/A02 cells. Our results suggested that compounds 7d, 7f, and 7l had anticancer effects, as well as multidrug resistance reversal effects.

Synthesis and Biological Evaluation of a Series of 6,7-Dimethoxy-1-(3,4- Dimethoxybenzyl)-2-substituted Tetrahydroisoquinoline Derivatives

Design and Synthesis of Tetrahydroisoquinoline Derivatives As Potential Multidrug Resistance Reversal Agents in Cancer.

Tetrahydroisoquinoline-Related Modulators of Multidrug Resistance in Cancer

Synthesis and Multidrug Resistance Reversal Activity of 1-Akyl-2-acetyl-1,2,3, 4-Tetrahydroisoquinoline Derivatives

1-Benzyl-1,2,3,4-tetrahydroisoquinoline Derivatives and Optically Pure Isomers As Novel Promising Multidrug Resistance (mdr) Reversing Agents

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Design, Synthesis and Antitumor Activity of 3-Substituted Quinolone Derivatives (I)

Design, Synthesis and Biological Evaluation of the Novel Antitumor Agent 2-Benzyl-3, 4-Dihydroisoquinolin-1(2h)-one and Its Derivatives

Synthesis, Molecular Modeling and Biological Evaluation of 2-Aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3h)-thione Quinolone Derivatives As Novel Anticancer Agent

Design, Synthesis and Biological Evaluation of Novel Tetrahydroisoquinoline Derivatives As P-glycoprotein-mediated Multidrug Resistance Inhibitors.

Synthesis and Antitumor Activity of 2,4,6-Trisubstituted Novel Quinazoline Derivatives Containing Trifluoromethyl

Design, Synthesis and Antitumor Activity Evaluation of 4,6,7-Trisubstituted Quinazoline Derivatives Containing Benzothiazole Moiety

Synthesis and in Vitro Antiproliferative Evaluation of Pyrimido[5,4-C]quinoline-4-(3h)-one Derivatives

Synthesis and Antitumor Activity Evaluation of 2,4,6-Trisubstituted Quinazoline Derivatives Containing Thiazole Structure

Synthesis and Primary Evaluation of Quinoxalinone Derivatives As Potent Modulators of Multidrug Resistance

Synthesis and Biological Evaluation of Novel Pyrimido[4,5-B]quinoline-2,4- Dione Derivatives As MDM2 Ubiquitin Ligase Inhibitors.

Synthesis, Docking and Biological Evaluation of Isoquinolonic Acid Derivatives

Antitumor Agents. 181. Synthesis and Biological Evaluation of 6,7,2 ',3 ',4 '-Substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones As A New Class of Antimitotic Antitumor Agents

6,7-Dimethoxy-2-{2-[4-(1H-1,2,3-triazol-1-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolines as superior reversal agents for P-glycoprotein-mediated multidrug resistance.

Design, synthesis and anti-tumor activity evaluation of 4,6,7-substitute quinazoline derivatives

Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline As Anticancer and Multidrug Resistance Reversal Agents